Clinical Trial Update: Safety and Efficacy Study of TG-873870 (Nemonoxacin) in Diabetic Foot Infections [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of nemonoxacin (TG-873870) for diabetic foot infections has completed with results posted in January 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Infection

Drugs mentioned

• Nemonoxacin (Nemonoxacin)

Snippet

Sponsor: TaiGen Biotechnology Co., Ltd. | Conditions: Diabetic Foot Infections | Phase 2 | Status: COMPLETED | Results posted: 2015-01-09